Fulcrum Therapeutics, Inc. (FULC)

Fulcrum Therapeutics Revenue

Fulcrum Therapeutics had revenue of $2.51M in the twelve months ending March 31, 2024, down -37.95% year-over-year. In the year 2023, Fulcrum Therapeutics had annual revenue of $2.81M, a decrease of -55.77%.

• Revenue (ttm): $2.51M
• Revenue Growth: -37.95%
• P/S Ratio: 160.71
• Revenue / Employee: $33,026
• Employees: 76
• Market Cap: 403.38M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.81M	-3.54M	-55.77%
Dec 31, 2022	6.34M	-12.82M	-66.90%
Dec 31, 2021	19.16M	10.34M	117.19%
Dec 31, 2020	8.82M	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.